Priority Income Fund: NAV $3.18, Tender Offer, PRIF-PL Delisting
Some links pay us a referral fee; each one says so. Disclosure
Updated November 18, 2026: the fund filed the final result of its October tender offer on November 17. Holders tendered 9,045,042 shares; the fund bought 1,621,556 at $2.97, about 17.93% of each request. The final Schedule TO-I/A (Amendment No. 1, accession 0001554625-26-000036) says the offer expired at 4:00 p.m. Eastern on October 30, 2026, that the 9,045,042 shares “exceeded the maximum number of Shares the Company offered to purchase,” and that of the 1,621,556 shares bought, 158 were first bought from beneficial holders of fewer than 100 shares and the rest pro rata, for approximately $4,816,021. The price, $2.97, was the NAV per share as of October 31, 2026: 5.7% below the $3.15 paid in July and 6.6% below the $3.18 of June 30 (our arithmetic). Demand was 5.6 times the number of shares offered (our arithmetic), against 6.6 times in July. The filing does not give a payment date, and it says nothing about the Series L preferred; since the September 22 proxy statement, EDGAR shows only the NYSE’s Form 25 of October 14, the October 22 correction and this amendment, and we found no filing confirming the Series L payment as of November 18. The $2.97 NAV of October 31 appears in this amendment; we found no separate NAV filing for that date, and the next periodic report due is the semiannual report for December 31, 2026.
Updated October 23, 2026: the fund corrected the result of its July tender offer on October 22. It bought 1,551,221 shares for approximately $4,886,346, not 1,550,812 shares for $4,885,054. Schedule TO-I/A Amendment No. 2 (accession 0001554625-26-000034) says that “due to an administrative error in connection with processing the shares tendered for repurchase, 2,368 shares” that were validly tendered were not reported to the fund. The fund and its transfer agent then arranged the repurchase of 410 of those shares, 237 of the total first bought from holders of fewer than 100 shares. The price ($3.15, the July 31 NAV) and the share of each request bought (15.23%) did not change. Nothing else has been filed since: the October 30 offer is still open, the June 30 NAV of $3.18 is still the latest, and we found no filing confirming the Series L payment as of October 23.
Updated October 21, 2026: the NYSE has filed to remove the 6.375% Series L preferred (PRIF-PL) from listing, under the rule for a class called for redemption. A Form 25 dated October 14, 2026 (accession 0000876661-26-000828), filed by the New York Stock Exchange, notifies the SEC of the removal of the “6.375% Series L Term Preferred Stock Due 2029” from listing and registration. It came on the first day on which the fund’s Rule 23c-2 notice of September 14 allowed it to redeem all of the series at $25 a share plus accrued but unpaid dividends from October 1, 2026. The form prints no narrative reason, but it names the rule it relies on, 17 CFR 240.12d2-2(a)(1), which covers a class where “The entire class of the security has been called for redemption, maturity or retirement” with notice given and funds deposited for payment. The NYSE cited the same provision for Series J in a Form 25 filed on April 24, 2026, the redemption date in that series’ notice. Under the rule a delisting is effective 10 days after the Form 25 is filed, here October 24, 2026, a Saturday, so Monday, October 26 would be the first session without the listing (our reading; the form prints no effective date). We found no later filing confirming the payment. It concerns only the preferred stock; the common shares were never listed. We rechecked EDGAR on October 21: nothing had been filed since the proxy statement of September 22 except that Form 25 (the next filing was the October 22 correction of the July result, above), so the June 30 NAV of $3.18 is still the latest, the offer closing October 30 is still open and its final amendment is not yet filed. The proxy shows 3,794,065 preferred shares outstanding on the September 21 record date, before any Series L redemption, and an annual meeting on December 17, 2026.
Quick answer
Priority Income Fund, Inc. (SEC CIK 1554625) is a non-listed closed-end fund that puts most of its money into the equity and junior debt of CLOs. Its common shares have no exchange and no market: the only way out is a tender offer the fund chooses to make. Its NAV was $3.18 a share on June 30, 2026, against $10.85 two years earlier, a fall of 70.7% (our arithmetic). In the offer that expired July 31, 2026, holders tendered 10,184,037 shares; the fund bought 1,551,221 at $3.15, or 15.23% of each request (the fund corrected its count on October 22 from 1,550,812). That offer was launched 322 days after the previous one expired (our arithmetic), the one the fund had said would be its “final regular quarterly tender offer.” In the next offer, which closed October 30, 2026, holders tendered 9,045,042 shares against 1,621,557 offered and the fund bought 1,621,556 at $2.97, the NAV of October 31, about 17.93% of each request (final amendment filed November 17, 2026). Net investment income was $0.36 a share in fiscal 2026 against $1.03 distributed, all of it return of capital. Figures are from the annual report filed August 31, 2026, the tender offer filed September 18, 2026 and its final amendment filed November 17, 2026. The tickers you may have seen (PRIF-PD, PRIF-PK, PRIF-PL) belong to the fund’s preferred stock, and on October 14, 2026 the NYSE filed a Form 25 to remove the Series L (PRIF-PL) from listing under the rule for a class called for redemption, after the fund’s notice of September 14 that it would redeem it.
Key takeaways
- Eleven offers in a row, July 2022 to January 2025, bought every share tendered, using the extra shares the tender rules allow. The next four did not: about 60% of each request in April 2025, about 43% in July 2025, 15.23% in July 2026 and about 17.93% in October 2026 (at $2.97, the NAV of October 31).
- Demand has outrun the cap by a wide margin: 9,045,042 shares tendered in October 2026 against 1,621,557 offered, 5.6 times (our arithmetic), after 6.6 times in July 2026 (10,184,037 against 1,550,812) and 2.3 times in July 2025. Between the July 2025 and July 2026 offers, from July 31, 2025 to June 18, 2026, the fund made none.
- NAV per share: $12.04 on June 30, 2022, $10.85 in 2024, $6.14 in 2025 and $3.18 in 2026. The fund reported NAV total returns of minus 34.21% in fiscal 2025 and minus 36.20% in fiscal 2026; $10,000 at the June 2022 NAV would have been about $4,850 four years later with distributions reinvested (our arithmetic from the four yearly returns).
- The payout is not income: fiscal 2026 net investment income was $0.36 a share against $1.03 of distributions, or 35% (our arithmetic), and the full $64.7 million was return of capital. The monthly rate fell from $0.1047 in July 2025 to $0.0333 in June 2026; the 12.58% the fund quotes is that $0.0333 a month against a $3.18 NAV.
- The adviser is paid on income, not on NAV: a 2.0% base fee on total assets and a 20% incentive fee above a 6% hurdle that ignores realized and unrealized losses. In fiscal 2026 that was $13.8 million, or 24.95% of the fund’s investment income (our arithmetic), in a year with $153.9 million of realized losses. The last prospectus charged a 6.75% sales load on Class R.
- CLO equity was 135.1% of net assets at June 30, 2026, investments were worth 70% of their cost (our arithmetic), and the $149.9 million of notes, revolver and preferred stock equalled 41.5% of total assets, up from 35.9% a year earlier (our arithmetic) even after $79.5 million of preferred was redeemed.
CSV · 310 rows
Priority Income Fund, Inc.: tender offers, NAV, distributions, fees, leverage and CLO holdings, 2022-2026
304 rows from annual and semiannual reports (Form N-CSR, N-CSRS), sixteen final tender-offer amendments (Schedule TO-I/A), the open offer (Schedule TO-I), the last prospectus (486BPOS), Form 8-K, the proxy statement and nine Form N-PORT reports: shares tendered and bought, NAV, income, distributions, fees, leverage, top holdings and the listing timeline.
What Priority Income Fund is, and what PRIS and PRIF-PK are
Priority Income Fund was incorporated in Maryland on July 19, 2012 and started operations on May 9, 2013. It is a registered closed-end fund that says it has “invested primarily in the equity and junior debt tranches” of CLOs, pools of below-investment-grade corporate loans. Its adviser, Priority Senior Secured Income Management, LLC, is 50% owned by Prospect Capital Management and 50% by Stratera Holdings; the fund shares an exemptive co-investment order with Prospect Capital Corporation (PSEC), Prospect Floating Rate and Alternative Income Fund (PFLOAT) and Prospect Enhanced Yield Fund (PENF). It sold shares to individuals through brokers from 2013 until the offering was suspended after the May 1, 2025 monthly purchase date, first at $15.00 a share.
The names that confuse searchers:
- The common shares come in three “classes” (Class R CUSIP 74272V107, Class RIA 74272V206, Class I 74272V305). They differ only in the sales load; every share has the same NAV and the same rights. The tender filing says plainly: “The Shares are not currently traded on an established trading market.” EDGAR’s company record lists no ticker for them. If you hold “PRIS” or a Priority position at a broker, you hold these.
- The tickers PRIF-PD, PRIF-PK and PRIF-PL are the fund’s preferred stock on the NYSE: Series D (7.000%, due 2029), Series K (7.000%, no maturity) and Series L (6.375%, due 2029; the NYSE filed a Form 25 on October 14, 2026 to remove it from listing, see the leverage section). A Yahoo quote for PRIF-PK is the price of Series K, which closed at $21.83 on June 30, 2026 against a $25 liquidation preference, 12.7% below it (our arithmetic). It says nothing about what the common shares are worth. Those are worth NAV, in a tender, when the fund agrees to buy.
This page reads the fund’s own filings. For how it compares with funds that must offer to buy back shares on a schedule, see the private credit redemptions tracker, the list of interval funds and the non-traded BDC list: Priority is none of those, and nothing in its charter makes it buy back shares.
Sixteen tender offers since 2022: who was paid in full
Priority makes tender offers under its share repurchase program, capped at 2.5% of the shares outstanding on the last day of the prior fiscal year per quarter, at a price equal to NAV. The table is built from the final amendment to each Schedule TO-I, which reports what was tendered and bought. The first two offers were sized in dollars; the rest in shares. “+0.2%” and similar mean the fund used the rule that lets an issuer buy up to 2% of its outstanding shares beyond the offer without extending it.
| Offer expired | Size of the offer | Shares tendered | Shares bought | Price (NAV) | Share of each request bought | Cash paid |
|---|---|---|---|---|---|---|
| Jan 21, 2022 | up to $4,857,783 worth | 1,058,449 | 382,795 | $12.69 | 36% (our arithmetic) | $4.86M |
| Apr 19, 2022 | up to $5,403,100 worth | 1,794,082 | 1,263,700 (extra 2.0%) | $12.77 | about 70% | $16.14M |
| Jul 26, 2022 | 922,548 shares | 842,655 | 842,655 | $12.08 | 100% | $10.18M |
| Oct 26, 2022 | 1,099,918 shares | 708,877 | 708,877 | $11.55 | 100% | $8.19M |
| Feb 2, 2023 | 1,099,918 shares | 1,194,710 | 1,194,710 (+0.2%) | $11.26 | 100% | $13.45M |
| May 4, 2023 | 1,099,918 shares | 1,337,603 | 1,337,603 (+0.5%) | $11.64 | 100% | $15.57M |
| Aug 2, 2023 | 1,099,918 shares | 1,195,889 | 1,195,889 (+0.2%) | $11.30 | 100% | $13.51M |
| Nov 1, 2023 | 1,347,196 shares | 1,015,614 | 1,015,614 | $11.15 | 100% | $11.32M |
| Feb 1, 2024 | 1,347,196 shares | 1,162,131 | 1,162,131 | $11.11 | 100% | $12.91M |
| May 1, 2024 | 1,347,196 shares | 1,746,750 | 1,746,750 (+0.7%) | $10.77 | 100% | $18.81M |
| Jul 31, 2024 | 1,347,196 shares | 2,337,277 | 2,337,277 (+1.4%) | $10.66 | 100% | $24.92M |
| Oct 31, 2024 | 1,516,379 shares | 1,634,831 | 1,634,831 (+0.2%) | $10.41 | 100% | $17.02M |
| Jan 31, 2025 | 1,516,379 shares | 2,725,984 | 2,725,984 (+1.9%) | $9.60 | 100% | $26.17M |
| Apr 30, 2025 | 1,516,379 shares | 2,521,667 | 1,518,958 | $7.17 | about 60% | $10.89M |
| Jul 31, 2025 | 1,516,379 shares | 3,552,367 | 1,634,626 (after a correction) | $6.09 | about 43% | $9.95M |
| Jul 31, 2026 | 1,550,812 shares | 10,184,037 | 1,551,221 (after a correction) | $3.15 | 15.23% | $4.89M |
| Oct 30, 2026 | 1,621,557 shares | 9,045,042 | 1,621,556 (158 first from holders of fewer than 100 shares) | $2.97 | about 17.93% | $4.82M |
The pattern is a squeeze that arrived in 2025. From July 2022 to January 2025 the fund bought everything it was asked for, in eleven straight offers, and at the January 2025 peak that meant 2,725,984 shares at $9.60. Then NAV fell from $9.60 on January 31, 2025 to $7.17 on April 30 and requests outgrew the cap: about 60% was filled in April 2025, about 43% in July 2025, 15.23% in July 2026 and about 17.93% in October 2026. Total cash paid in the sixteen offers completed before October 2026 is $218.8 million (our sum of the sixteen amounts); the October 2026 offer added about $4.8 million, for about $223.6 million in seventeen offers (our sum); the three prorated offers before October paid $25.7 million (our sum).
Three details from the filings change how to read the table:
- The annual report counts differently. For the offers from July 2024 to July 2025 the repurchase table in the annual report shows more shares than the final amendments: 2,403,947 for the July 2024 offer against 2,337,277, and 1,529,263 for April 2025 against 1,518,958 (it prints 60.07% for April and 42.67% for July 2025). We use the amendments, except where the fund filed a correction. In October 2025 it reported an administrative error: 277,115 shares tendered in the July 2025 offer had not been reported to it, and it repurchased 118,247 of them later, bringing that offer to 1,634,626 shares and $9,954,873. The amendment for the April 2025 offer reported 4,289 shares missed the same way.
- The two earliest offers in the table were prorated too. In January 2022 the fund bought about 36% of what was tendered and in April 2022 about 70% (our arithmetic for January, the fund’s figure for April). Full payment was the exception that ran from July 2022 to January 2025.
- The July 2026 offer was corrected too. The first final amendment (August 14, 2026) reported 1,550,812 shares bought for approximately $4,885,054. On October 22, 2026 Amendment No. 2 added 410 shares that an administrative error had left out, for 1,551,221 shares and approximately $4,886,346, still 15.23% of each request at $3.15. The 1,550,812 in the offer-size column is the size of the offer.
322 days with no offer
The fund’s 2026 annual report says that on June 20, 2025 it announced that the offer expiring July 31, 2025 “would be the Company’s final regular quarterly tender offer under its share repurchase program.” Two months earlier, on April 25, 2025, it had announced that it intended to list its shares on an exchange, and its board suspended the sale of new shares after the May 1, 2025 purchase date. The next tender offer was launched on June 18, 2026, 322 days after the previous one expired (our arithmetic). No offer was made in October 2025, January 2026 or April 2026, although the annual report still describes the program as quarterly.
A holder who wanted out in October 2025 had no offer to tender into; by the next pricing, July 31, 2026, NAV was $3.15, 48% below the $6.09 of the offer before (our arithmetic).
The October 2026 offer: 17.93% filled at $2.97
The final amendment filed November 17, 2026 (accession 0001554625-26-000036) closes the offer that the Schedule TO-I of September 18, 2026 (accession 0001554625-26-000027) opened. It was for up to 1,621,557 shares, 2.5% of the 64,862,285 outstanding at June 30, 2026. Holders tendered 9,045,042; the fund bought 1,621,556 for approximately $4,816,021 at $2.97, the NAV per share as of October 31, 2026, about 17.93% of the shares tendered by each participating holder.
| Measure | July 2026 offer (expired Jul 31) | October 2026 offer (expired Oct 30) |
|---|---|---|
| Shares offered | 1,550,812 | 1,621,557 |
| Shares tendered | 10,184,037 | 9,045,042 |
| Shares bought | 1,551,221 (as corrected Oct 22) | 1,621,556 |
| Share of each request bought | 15.23% | about 17.93% |
| Price (NAV per share) | $3.15 (Jul 31, 2026) | $2.97 (Oct 31, 2026) |
| Cash paid | approximately $4,886,346 | approximately $4,816,021 |
| Source | Amendment No. 2, accession 0001554625-26-000034 | Amendment No. 1, accession 0001554625-26-000036 |
What a holder of 10,000 shares who tendered all of them received in October, using the fund’s 17.93% (our arithmetic): 1,793 shares sold for about $5,325 at $2.97, with 8,207 shares still held. The terms below are those the offer stated when it opened on September 18, 2026 (63,721,527 shares and 12,578 holders of record as of that date):
- Deadline: 4:00 PM Eastern, October 30, 2026, unless extended; it was not extended. The price was the NAV of October 31, the day after holders had to tender, so they did not know the price when they decided. The example the fund gave was the July 31 NAV of $3.15, which would have made the full offer $5,107,905; at the actual $2.97 the 1,621,556 shares cost about $4.82 million.
- Proration: if more is tendered, the fund buys pro rata, with priority for holders of fewer than 100 shares who tender all of them. “Any shares not purchased during the tender offer period will need to be re-submitted for repurchase in subsequent offers at the subsequent per-share price.” Nothing carries over.
- No promise of a next offer. The company may offer to repurchase shares “at such times and on such terms as may be determined by the Board,” and has no obligation to buy if a repurchase would breach the distribution limits of federal or Maryland law.
- Cost and tax: the fund charges nothing; a broker may charge a processing fee. For most stockholders the sale is taxable. Tendered shares can be withdrawn until the expiration, and after November 17, 2026 if not accepted.
- Why the fund does it: “The purpose of this Offer (as defined below) is to provide stockholders with liquidity because there is otherwise no public market for the Shares.”
What the July 2026 result meant for a holder, using the fund’s own percentages (our arithmetic): a holder of 10,000 shares who tendered all of them sold 1,523 shares for about $4,797 at $3.15 and still held 8,477. October was slightly better on the fill and worse on the price: 17.93% at $2.97, so the same 10,000 shares brought about $5,325 for 1,793 shares. Tendering the 8,207 left in October would have required a further offer. At the cap, four offers a year would retire 6.5 million of the 63.7 million shares a year, about ten years to clear them all (our arithmetic); the fund has now made two offers in the last twelve months, in June and September 2026, and a third has not been announced in the filings we read.
NAV: $12.04 to $3.18 in four years
| Date | NAV per share | Where it comes from |
|---|---|---|
| Jun 30, 2021 | $12.15 | Fiscal 2021 year-end, financial highlights |
| Dec 31, 2021 | $12.66 | Semiannual report (Form N-CSRS) |
| Jun 30, 2022 | $12.04 | Annual report (Form N-CSR) |
| Dec 31, 2022 | $11.39 | Semiannual report |
| Jun 30, 2023 | $11.31 | Annual report |
| Dec 31, 2023 | $11.24 | Semiannual report |
| Jun 30, 2024 | $10.85 | Annual report |
| Dec 31, 2024 | $9.52 | Semiannual report |
| Jan 31, 2025 | $9.60 | Price of the tender offer |
| Apr 30, 2025 | $7.17 | Price of the tender offer |
| Jun 30, 2025 | $6.14 | Annual report |
| Jul 31, 2025 | $6.09 | Price of the tender offer |
| Dec 31, 2025 | $4.48 | Semiannual report |
| Jun 30, 2026 | $3.18 | Annual report |
| Jul 31, 2026 | $3.15 | Price of the tender offer |
For three years NAV barely moved: down 6.1% in fiscal 2023 and 4.1% in fiscal 2024 (our arithmetic), and the fund’s September 2023 letter put the fiscal 2023 fall down to “market yields for CLO equity and debt widening with the overall increase in prevailing interest rates.” Then it fell 43.4% in fiscal 2025 and 48.2% in fiscal 2026 (our arithmetic). Net assets applicable to common shares went from $658.0 million at June 30, 2024 to $380.9 million a year later and $206.2 million at June 30, 2026, down 68.7% (our arithmetic); total assets fell from $983.3 million to $361.3 million. Quarter by quarter on Form N-PORT, net assets were $643.8 million, $591.4 million, $443.3 million, $380.9 million, $319.0 million, $281.5 million, $231.2 million and $206.2 million from September 2024 to June 2026. New money stopped: monthly sales of shares were zero from June 2025.
The fund’s own per-share bridge shows where each of the last two years went:
| Per share | Fiscal 2025 (to Jun 30, 2025) | Fiscal 2026 (to Jun 30, 2026) |
|---|---|---|
| NAV at the start of the year | $10.85 | $6.14 |
| Net investment income | +$0.72 | +$0.36 |
| Net realized and unrealized loss on investments | -$4.00 | -$2.22 |
| Loss on repurchase of preferred stock | -$0.02 | -$0.02 |
| Dividends on Series K preferred | -$0.05 | -$0.04 |
| Distributions to common stockholders | -$1.34 | -$1.03 |
| Other (balancing figure in the filing) | -$0.02 | -$0.01 |
| NAV at the end of the year | $6.14 | $3.18 |
| Total return based on NAV, as reported | -34.21% | -36.20% |
Where the NAV went: losses on CLO equity, realized
In fiscal 2025 the fund booked a net realized loss on investments of $178.0 million and a net unrealized loss of $68.7 million; in fiscal 2026 the realized loss was $153.9 million, with a $13.6 million unrealized gain. Together, $332.0 million of realized losses in two years (our sum) against a fund that had $658.0 million of net assets at the start.
The fund’s explanation, in the 2026 letter, is the loan market: “elevated defaults (including distressed exchanges) coupled with declining loan asset spreads,” which it says has persisted for three years. It adds that these dynamics “have pressured CLO equity investments by reducing collateral levels and impairing income potential.” The fund also points out that its own trailing twelve-month default rate including distressed exchanges was 1.30% at June 30, 2026 against 2.77% for the market, and that the loans under its CLOs had a 0.68% default rate. Our reading: defaults in the collateral do not by themselves explain a 48% fall in a year, and the filing does not break the marks down by CLO. The schedule of investments carries many older equity positions at an estimated yield of zero because, as footnote 6 says, “The effective yield has been estimated to be 0% as expected future cash flows are anticipated to not be sufficient to repay the investment at cost.”
What the portfolio looked like at June 30, 2026:
| Measure | June 30, 2026 |
|---|---|
| Investments at fair value / amortized cost | $329.5M / $469.7M, or 70% of cost (our arithmetic) |
| CLO equity (subordinated and income notes) | $278.6M, 135.1% of net assets; cost $376.8M |
| CLO debt tranches | $50.9M, 24.7% of net assets |
| Share of total assets in CLO equity and debt | 91.2% (our arithmetic) |
| Loans underneath the CLOs | 1,523; largest borrower 0.52%; ten largest 4.08% |
| Collateral rated B (Moody’s / S&P) | 62.03% / 62.23%; Caa/CCC and lower 7.26% / 7.16% |
| Valuation | all investments are Level 3, valued by the board |
| Largest position | Cedar Funding IV CLO, $14.8M, 7.2% of net assets |
| Ten largest positions | $103.5M, 50.2% of net assets (our sum) |
The ten largest are all CLO subordinated notes: Cedar Funding IV ($14.8 million), Voya CLO 2022-1 ($13.2 million), Voya CLO 2019-1 ($11.7 million), Redding Ridge 5 ($11.0 million), Rad CLO 28 ($10.7 million), Rockford Tower 2024-2 ($9.1 million), Columbia Cent CLO 29 ($8.8 million), AGL CLO 33 ($8.5 million), BBAM US CLO 6 ($7.9 million) and CIFC Funding 2019-7 ($7.8 million). The letter says the fund bought 29 CLO investments ($103.5 million) and sold 24 in fiscal 2026, raised its mix of BB-rated CLO debt by 5.9% and cut CLO equity by 3.7%, and sold three more CLO equity positions for about $11.7 million after year-end. All investments are pledged to the revolver.
The distribution: 12.58% of a $3.18 NAV, and 35% covered
| Fiscal year (to Jun 30) | Net investment income per share | Distributions per share | Of which return of capital | Income divided by distributions (our arithmetic) |
|---|---|---|---|---|
| 2022 | $1.83 | $1.33 | none reported | 138% |
| 2023 | $2.16 | $1.36 | none reported | 159% |
| 2024 | $1.31 | $1.36 | none reported | 96% |
| 2025 | $0.72 | $1.34 | $1.15 | 54% |
| 2026 | $0.36 | $1.03 | $1.03 | 35% |
In dollars the picture is the same: fiscal 2026 net investment income of $22.6 million against $64.7 million distributed (35%, our arithmetic), after $44.4 million against $83.1 million in fiscal 2025 (53%). The cash paid out was $42.7 million; the other $22.0 million was reinvested into 4,464,423 new shares. The expected tax character of the whole $64,720,361 is return of capital, with no ordinary income; the fund adds that the final character is set on its tax return. For a holder that means the cash was, in the fund’s accounting, a return of your own money, which generally reduces cost basis rather than counting as income; see our 1099-DIV page for when the form arrives.
The monthly rate per share, by record date: $0.104727 on July 3, 2025 (with bonus), $0.124867 on August 5 (with bonus), $0.080560 on December 2, $0.058330 from March to May 2026, and $0.033330 on June 26, 2026, the same rate declared for July and August 2026. That is a 68% cut from July 2025 (our arithmetic). Twelve times $0.03333 is $0.40, or 12.58% of $3.18, which is the figure in the fund’s letter, and 12.7% of the July 31 NAV of $3.15 (our arithmetic). At the cut rate, income of $0.36 a share would cover about 90% of it (our arithmetic); at the fiscal 2026 rate it covered 35%.
How the fund described its payout before the fall matters. In the annual report for June 30, 2025 it said it had paid an annualized yield of 21.83% on a NAV of $6.14, “covering 135% of the Company’s last twelve months’ net investment income exclusive of paid-in-kind interest and CLO equity adjustments.” Read plainly, the payout was larger than that adjusted income; on the audited statements, net investment income was $0.72 a share against $1.34 distributed. The annual report for 2026 no longer makes a coverage claim. Its dividend policy keeps the sentence “Our distributions may exceed our earnings, and portions of the distributions that we make may therefore be a return of the money that you originally invested and represent a return of capital to you for tax purposes.”
Fees and share classes
| Item | Terms | What the filings show |
|---|---|---|
| Base management fee | 2.0% a year of average total assets, paid quarterly, plus up to 0.25% a year of adviser overhead | $9,400,037 in fiscal 2026 ($17,306,617 in fiscal 2025) |
| Incentive fee | None below 1.5% a quarter (6.0% annualized) of pre-incentive net investment income on net assets; 100% of income between 6.0% and 7.5% annualized; 20% above | $4,379,766 in fiscal 2026 ($10,762,563 in fiscal 2025) |
| What the incentive fee ignores | Pre-incentive net investment income excludes realized and unrealized capital losses | Paid in a year with $153.9M of realized losses |
| Sales load, Class R (last prospectus, Oct 2024) | 6.75% (6.0% commission + 0.75% dealer manager fee) plus up to 1.00% offering expenses | Class RIA: dealer manager fee only. Class I: none |
| Total annual expenses | Prospectus estimate 10.11% of net assets (management 2.89%, incentive 1.88%, interest 3.13%, other 2.21%) | Actual ratio to average net assets: 11.07% in fiscal 2026, 10.63% in 2025 |
| Other charges to the fund | Administrator costs (Prospect Administration); services-agreement costs up to 0.25% a year of net assets | $4,007,053 and $503,638 in fiscal 2026 |
| Expense support or limitation | None in the five-year financial highlights | No expense support repayments in fiscal 2022 to 2026 |
| Minimums | $1,000 initial and $500 additional, in the last prospectus | The offering of new shares is suspended |
Total investment advisory fees were $13,779,803 in fiscal 2026, which is 24.95% of the fund’s $55,227,741 of investment income, and $41.8 million over fiscal 2025 and 2026 (our arithmetic). The incentive fee is calculated on income each quarter and nothing in the fee terms reduces it for NAV that has already been lost, which is why it was still $4.4 million in a year when NAV fell 48%.
A Class R buyer in October 2024 paid $11.25 for a share with a NAV of $10.49, 7.2% above it (our arithmetic), before the fall to $3.18.
Leverage: preferred stock, notes and a revolver
| Instrument | Amount at June 30, 2026 | Rate | Maturity or call | Note |
|---|---|---|---|---|
| Revolving credit facility | $25.0M drawn | 1-month SOFR + 3.25% | Sep 28, 2028; amended Aug 21, 2026 to Feb 21, 2030 | Commitment cut from $75.0M to $40.0M; all investments pledged |
| 2035 notes (unsecured) | $30.0M | 6.50% | Mar 31, 2035 | Private placement |
| Series D term preferred (PRIF-PD) | $27.35M | 7.000% | Jun 30, 2029 | Closed at $24.75 on Jun 30, 2026 |
| Series L term preferred (PRIF-PL) | $27.5M | 6.375% | Mar 31, 2029; notice to redeem on or after Oct 14, 2026 | Closed at $24.42; $25 plus accrued dividends; NYSE Form 25 filed Oct 14, 2026 under Rule 12d2-2(a)(1), delisting effective Oct 24 under the rule; payment not yet confirmed by a filing |
| Series K cumulative preferred (PRIF-PK) | $40.0M | 7.000% | No maturity; callable from Sep 30, 2026 | Closed at $21.83; counted outside liabilities |
| Total | $149.85M (our sum) | 41.5% of total assets; 72.7% of common net assets (our arithmetic) |
The fund redeemed $79.5 million of preferred in fiscal 2026 (all of Series I, $40.0 million on July 14, 2025, and Series J, $19.75 million on February 25 and $19.75 million on April 24, 2026), after earlier calls of Series F, G and H. It still got more leveraged in relative terms: revolver, notes and preferred were $214.1 million against $596.7 million of total assets a year earlier, 35.9% (our arithmetic). The reason is that assets fell faster than debt. The asset coverage per $25 preferred share printed in the annual report went from $76 (June 2024) to $69 (2025) to $59 (2026), about 2.4 times the $25 liquidation preference. On September 14, 2026 the fund gave notice that it intends to redeem all Series L shares on or after October 14, 2026; it held $29.8 million of cash at June 30. On October 14, 2026 the NYSE filed a Form 25 to remove the Series L from listing and registration, relying on Rule 12d2-2(a)(1), the provision for a class that has been called for redemption; the same provision was cited for Series J on April 24, 2026, the redemption date in that series’ notice. The rule makes the delisting effective 10 days after filing, October 24, 2026. We found no filing yet confirming the payment. Preferred stock ranks ahead of the common shares for dividends and in liquidation.
In fiscal 2026 the fund paid $8,290,936 in cash dividends on its preferred stock and $2,680,866 in interest, ahead of common holders.
The listing that was promised
| Date | What the fund said | Source |
|---|---|---|
| Apr 25, 2025 | Announced its intention to list its common stock on an exchange; offering of new shares suspended after the May 1 purchase date | Form 8-K filed Jun 20, 2025; annual report |
| Jun 20, 2025 | The listing would occur “within the twelve months following such announcement,” subject to market conditions, stockholder approval and board approval | Form 8-K |
| Aug 28, 2025 | Annual report: “a target listing date in the first half of 2026” | Form N-CSR |
| Sep 18, 2025 | Proxy statement: the listing “is expected to occur prior to December 31, 2026” | DEF 14A |
| Jan 8, 2026 | Stockholders approved a charter amendment limiting sales for 270 days after a listing, subject to final board approval | Annual report note |
| Aug 31, 2026 | Listing conditions, including discounted trading of comparable funds, “not yet justifying such execution” | Form N-CSR letter |
On the wording of the June 2025 filing, the twelve months ended on April 25, 2026 without a listing, and the fund’s 2026 letter says conditions do not yet justify one. The September 2026 tender offer says the fund has no present plans for a merger, reorganization or liquidation, and lists a listing, a merger or an asset sale as the ways a holder could ultimately get liquidity apart from tenders. A listing would change the exit from NAV in a tender to a market price, and the fund’s own letter refers to “significantly discounted trading levels versus net asset value for comparable funds.” Our listing-discount page shows what that looked like for non-traded REITs; it is a different asset class, so read it as a pattern, not a forecast. Even if a listing happens, the approved charter amendment would restrict selling for the first 270 days.
What a holder can do with this
- If you want out: as of November 18, 2026 the filings show no open offer; the October one closed with 17.93% filled at $2.97. Tender offers are the only route the filings describe, and none has been announced. The tender terms said that shares not bought “will need to be re-submitted for repurchase in subsequent offers at the subsequent per-share price”; nothing carries over. The pattern of two offers in the last six months, each filling under 18%, is a fact to weigh, not a forecast.
- If you are weighing whether to wait: the filings give you three things to weigh, not a prediction. The NAV went from $3.18 (June 30) to $3.15 (July 31) to $2.97 (October 31); requests were 5.6 times the cap in October and 6.6 times in July; and the fund has not promised a next offer. Waiting means accepting any NAV change before a later offer, and the possibility that the board makes none.
- If you sell at a loss: a tender sale is a taxable sale for most holders, and the distributions you received were return of capital, which reduce basis. A tax professional can tell you what that does to your loss; we cannot.
- What to watch next: any announcement of a January 2027 offer (the October result is already filed), a filing confirming the Series L redemption (the NYSE’s Form 25 for it is dated October 14 and, by the rule, takes effect for the listing on October 24), Series K call rights that began September 30, the December 17, 2026 annual meeting (only one preferred-stock director is on the ballot), the semiannual report for December 31, 2026, due around late February 2027, and any listing announcement. Our evergreen funds comparison shows how other private funds handle the same question.
- If you hold the preferred stock instead: PRIF-PD, PRIF-PK and PRIF-PL are exchange-traded; the fund’s own report calls their trading volume low. They are a different security with a different risk. This page is about the common shares.
FAQ
Filing alert · free
An email when Priority Income Fund files with the SEC
An email the day Priority Income Fund files something new, with the link to the document on the SEC site.
All figures are from Priority Income Fund, Inc.’s SEC filings (CIK 1554625) read on EDGAR on October 8, 2026 and rechecked on October 21 and 23 and November 18, 2026 (including the final Schedule TO-I/A of November 17, 2026, accession 0001554625-26-000036, and the Schedule TO-I/A Amendment No. 2 of October 22, 2026, accession 0001554625-26-000034, and the NYSE’s Form 25 of October 14, 2026, accession 0000876661-26-000828, and Rule 12d2-2, 17 CFR 240.12d2-2): annual reports on Form N-CSR for the years ended June 30, 2022 to 2026 (accessions 0001554625-22-000129, 0001554625-23-000088, 0001554625-24-000040, 0001554625-25-000057 and 0001554625-26-000022); semiannual reports on Form N-CSRS for December 2021 to December 2025 (0001554625-22-000066, -23-000032, -24-000009, -25-000010 and -26-000005); the final Schedule TO-I/A amendment of each of sixteen tender offers (January 2022 to July 2026, including the corrections of May and October 2025: 0001554625-25-000039 and 0001554625-25-000083); the Schedule TO-I and Offer to Purchase of September 18, 2026 (0001554625-26-000027); the prospectus supplement filed October 25, 2024 (0001554625-24-000059); Form 8-K of June 20, 2025 (0001554625-25-000046); the proxy statement of September 18, 2025 (0001554625-25-000077); the notice under Rule 23c-2 filed September 14, 2026 (0001554625-26-000024); and nine Form N-PORT reports from June 2024 to June 2026. Percentages, sums, ratios and the illustration for a 10,000-share holder are our arithmetic. This is analysis of public documents, not investment, legal or tax advice.